永胜医疗2025年年报

23782025101218244979135140141142143144146220 Cricket Square, Hutchins Drive,P.O. Box 2681, Grand Cayman,KY1-1111, Cayman Islands 222161604-07A 2829 Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins Drive,P.O. Box 2681, Grand Cayman,KY1-1111, Cayman Islands 20258202025820 1617 20258202025820202582020258202025820 (852) 2155 2998(852) 2155 8298investors@vincentmedical.com 20258202025820 1612 www.vincentmedical.com 135219 財務摘要 深耕全球市場 國家及權威認可 永勝醫療全年足跡遍及廣州、上海、長沙、廈門、香港等多個城市，以及德國、美國、新加坡、阿聯酋、印度、日本等國家。搭建與全球客戶及同業交流合作的橋樑，提升品牌的國際影響力。 專精特新「小巨人」企業 憑藉卓越的創新能力與深耕醫療領域的專業實力，成功獲評國家級專精特新「小巨人」，標誌著其在產業鏈關鍵環節已構建顯著核心競爭優勢。 濕熱交換過濾器性能優異 榮獲多項權威榮譽 年內，永勝醫療獲得多項權威認可：榮獲「深圳市科技進步獎二等獎」與東莞市「高新科技產品」認定，並獲得「公益慈善榜樣稱號」、「開平市慈善捐贈獎」等公益獎項。 三款濕熱交換過濾器憑藉優異產品性能，獲國際呼吸科權威雜誌刊載介紹，躋身市面優異過濾器20款之列*。 產學研協同賦能 數智轉型加速 永勝醫療與武漢紡織大學、東莞理工學院、電子科技大學廣東電子信息工程研究院達成戰略合作，致力培養更多適應需求的人才，實現校企協同共贏。 技術創新 開平翠山湖研發生產基地建設穩步推進，智能倉儲系統成功落地，為全鏈條智能升級奠定基礎。 持續推動創新，全年新授權專利52個，其中發明專利35個，其中有29個為海外發明專利。 20251231 2024 2025(SKU) 16.5%932.82024801.0104.4202469.250.9% 2.620241.72.420241.620255.020243.3 2026 2026325 管理層討論及分析 20251231 (AIoT) 2.620241.72.420241.620255.020243.3 OEM 393.3549.739.8%58.9%202449.1%34.8%202431.6% 管理層討論及分析 243.22024245.526.1%202430.6%39.3%2024 38.1% 4.3%107.12024111.9202511.5%202414.0% 50.232.83.5%20246.3%28.7%202431.7% 20252026 932.82024801.016.5% 43.6%39.5%202432.0%32.0%202436.5%0.5%75.58.1%20249.4% 25.9%327.42024260.032.5%35.1% 0.320241.5 9.5%43.0202439.24.6%20244.9% 5.0%106.32024112.011.4%202414.0% 管理層討論及分析 48.7202430.65.2%2024 3.8% 21.320247.1 104.4202469.2 121.02024142.420251231323.72024220.5 2025123175.82024118.8 2025123161.6202449.831.0202419.5 20251231154.72024162.7 20251231194.82024169.3 2025123135.9202431.6 20251231113.8202475.0 2025123160.7202441.6 20251231230.72024170.6 20251231250.92024173.42.020242.2 20251231146.4202480.2 20251231478.42024487.0 202512311,46820241,328 240.12024214.425.7%202426.8% 202512316.620246.5659,049,8322024653,336,3320.01 20251231 214.02024132.730.7202430.420251231 20251231 7347(i)(ii)(iii)VRI 4420205(i)(ii)(iii)VRI 2005520146409(MIS) (i)HKMTA(ii)(iii)(iv)20232025 20Bayer AGVRHK1412.HK2232.HK 5220009 20006200952007140920084 董事及高級管理層履歷 HKMTA20172022HKMTA 551997628 1997122009102008420071 6820237202092019720166242019613198611997819978200912009120181 1982121990720094 672016619823198410(University of New South Wales) HKMTA(i)(ii)(iii)(iv)(v)20232024HKMTA 董事及高級管理層履歷 (i)1+(ii)2022202420192025 41 672016619827(University of East Anglia)200010198711 4019821019871019871219891Arthur & Anderson & Co.199282008420021020199 8319.HK 7620172 197519761985 2015 1986 董事及高級管理層履歷 442018720051121 502016421 55201612inspiredTMOBM 21 19937(University of Bradford)199820142022 20222024201420152017201820212022 董事及高級管理層履歷 542004322 4520161020031220091219 592018819909Infineon Technologies AGInfineon Technologies (Kulim) Sdn. Bhd.29 5020141027 62201810PMC198481987826 472023122001719MRIFDAFDA 董事及高級管理層履歷 5120243200011669.HK20 46202311200463886.HK16 20251231 4210 20251231 (a) (b) (c) (d) 70.7% (e) (f) (g) (h) (i) (j) (k) (l) AI (m) 2019 (n) 6 OEM 202512312.620241.720259262.420241.6202512315.020243.3 17.120265202025123120261231 (1)2026520202651520265202026514430 (2)20266120265282026612026527430 (3)1617 29(b) 20251231208.7 20251231 18 28 20251231 60,0002024143,000 70.7%202463.9%59.6%2024 50.6% 36.6%202432.8%11.6%2024 12.9% 5% 84(1)(2) 13.51B(1) 202513.51B(1) 202513.51B(1) 20251231 15(c)41 15(c)41 20251231XVXV78352 (1)L (2) (a)11,000,000(b)VRI381,939,890VRI57.89%VRI(c)VRHK250,000VRIVRHKVRHK (4)20251231VRI42.11%VRI (a)9,700,000(b)2,000,000 (6) (a)4,941,166(b)174,000(c)528,834(d)2,001,166 (7) (a)5,691,166(b)396,000(c)528,834 (d)1,251,166 (8)20251231659,049,832 20251231XVXV78352 20251231XV23336 (1)L (a)11,000,000 (c)VRHK250,000VRIVRHKVRHK (3) (a)VRI381,939,890 (b)VRHK250,000VRIVRHKVRIVRHK (4)20251231659,049,832 20251231XV23336 1.2016617 20166172026616 2016617910.8020167131.0080%19,684,0001.002016617 147,0000.95 20261166,0000.92 202512311,839,6681,773,6680.28%0.27% 2.20166242024522 201662420245222024522 63,800,00010%121% 20251231 (i) (ii) (iii) 1.005 5,566,5001.03117,000 202611150,0000.87 2025123121,902,83221,752,8323.32%3.30% 3.2024522 20245221720231120345212024419 (i)(ii)(iii) 211.00 12 2025112025123165,333,63310%9.91%9.91% 4.20211222024522 20211222024522202311172024419 (a)(b)2031121 (i)(1)(2)(ii)17 12 2025112025123132,820,5165.02%4.98%4.98% 2025123110,000,0001.52% 5. 10%1%202452265,333,6336,533,36310%1% 2025112025123165,333,63310%10%9.91%9.91%202511202512316,533,3631%1%0.99%0.99% 12 (1) (2) 0202512 31655,053,25410,000,0000% 31 15(a)14(b) 25% 2016624 202512312026520 41 VRDG20241217202531914A VRDGVRI14AVRDG 2.2025123120251215VRDG2026112027123120251215 VMDGVRDG5.8VMEVRDG2.3 (i) (ii) (iii)VRDG (iv) (v)14A.55(i)(ii)(iii) (vi)14A.56300074014A.56